6 completed, 3 unknown, 2 not yet recruiting. 9 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Completed 5, Not yet recruiting 2, Unknown 2 |
| Phase 1 | 1 | Completed 1 |
Follow VISUfarma SpA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of EPD-09-25 for Eyelid Hygiene Before and After Eye Surgery. EPD Eyelid wipes - Cataract Surgery, Ocular Infections | Not applicable | Not yet recruiting | VISUfarma SpA | 100 | 2026-04-01 | 2026-02-20 |
| Efficacy and Safety of VMX Eye Drops for Dry Eye Disease VMX Eye Drops, placebo eye drops - Dry Eye Disease (DED) | Not applicable | Not yet recruiting | VISUfarma SpA | 76 | 2026-02-02 | 2026-01-29 |
| VISUPRIME® Eye Drops VISUPRIME, Placebo - Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation | Not applicable | Completed | VISUfarma SpA | 78 | 2023-06-22 | 2024-07-19 |
| The Usefulness of Visuprime in Cataract Surgery Visuprime, Placebo - Cataract | Not applicable | Completed | VISUfarma SpA | 75 | 2021-10-25 | 2024-08-01 |
| Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED VisuXL® Gel, HYLO® - Dry Eye Syndromes | Not applicable | Unknown | VISUfarma SpA | 90 | 2020-07-06 | 2020-07-24 |
| Evaluate the Improving Effects of Visucomplex Plus on Quality of Life in Patients With AMD Visucomplex Plus - AMD | Unknown | VISUfarma SpA | 160 | 2019-12-11 | 2020-04-27 | |
| Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma CoQ10- MINIACTIVES, Placebo - Glaucoma, Open-Angle | Not applicable | Unknown | VISUfarma SpA | 70 | 2019-09-01 | 2020-04-28 |
| Evaluation of MAF-1217 in Patients With DED MAF1217, Cationorm - Evaporative Dry Eye Disease | Not applicable | Completed | VISUfarma SpA | 72 | 2018-11-27 | 2019-07-15 |
| Evaluation of the Performance of MAF-1217 on Cataract Surgery MAF-1217 - Dry Eye | Not applicable | Completed | VISUfarma SpA | 46 | 2018-11-20 | 2019-07-15 |
| Evaluation of the VisuXL® Performance on Ocular Surface Discomfort VisuXL® - Ocular Discomfort | Not applicable | Completed | VISUfarma SpA | 20 | 2018-10-08 | 2019-02-18 |
| Bioavailability Study of COQUN ORAL FORMULATION COQUN ORAL FORMULATION - Male & Female Healthy Volunteers | Phase 1 | Completed | VISUfarma SpA | 24 | 2018-06-22 | 2019-09-06 |
Dry Eye Syndromes (4) · Cataract (1) · Disease (1) · Eye Infections (1) · Glaucoma, Open-Angle (1) · Macular Degeneration (1)
Cationorm (1)
Italy (8) · France (1) · Romania (1) · Spain (1)
Anna Rita Bigioni (2) · Anna R Bigioni (1) · Anna Rita Bigioni, PhD (1)